United States securities and exchange commission logo

                          June 23, 2022

       Eric A. Adams
       President and Chief Executive Officer
       InMed Pharmaceuticals Inc.
       815 W. Hastings Street, Suite 310
       Vancouver, B.C. V6C 1B4

                                                        Re: InMed
Pharmaceuticals Inc.
Statement on Form S-1
                                                            Filed June 21, 2022
                                                            File No. 333-265731

       Dear Mr. Adams:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Chris
Edwards at 202-551-6761 with any questions.


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Brian Fenske, Esq.